Biosimilar Insights
-
A Closed And Automated Solution To Streamline Your Workflow
3/27/2024
Whether it's dilution, mixing, cryopreparation, or splitting of cellular products, ReadySelect offers a comprehensive solution for your up- or downstream cell therapy manufacturing workflow.
-
A Flexible Solution To Automate Concentration, Washing, And Formulation
3/27/2024
Enjoy the flexibility of user-definable parameters, allowing you to tailor each step of your process, including concentration via continuous flow, washing, resuspension, and final formulation.
-
Reducing Costs Via Automated And Closed Systems
3/27/2024
By embracing these advanced technologies, learn how you can streamline your operations, enhance accuracy, and mitigate risks effectively.
-
Gain Support For Your Regulatory Submission Process
3/27/2024
Join us in this video as we delve into invaluable tips, cutting-edge tools, and unwavering support that Cytiva offers to facilitate your documentation progress.
-
Cell Therapy Process Development Made Easy
3/27/2024
Explore how Fast Trak™ process development services offered by Cytiva can guide you through achieving GMP compliance in your cell therapy manufacturing process.
-
Top Challenges In Recombinant Protein Purification Process Development
3/27/2024
Get insights from process developers working with recombinant proteins that cannot be purified with affinity chromatography.
-
Next Generation Conjugates: Process And Analytical Challenges
3/25/2024
Explore specific examples of challenges commonly encountered in the process and analytical development of next-generation conjugates as well as corresponding solutions for each.
-
AAV Process Intensification Using High Salt Lysis And Salt Tolerant Endonuclease
3/25/2024
In the production of adeno-associated virus (AAV) vectors, cell lysis involves challenges addressed through high salt concentrations and a salt-tolerant endonuclease, enhancing titer and infectivity.
-
AAV Process Intensification Using High Salt Lysis & Salt Tolerant Endonuclease
3/25/2024
Examine how intensifying AAV production with high salt lysis and Benzonase® Salt Tolerant endonuclease enhances viral yield and infectivity while ensuring DNA removal for patient safety.
-
The AI Impact with Generate:Biomedicines' Mike Nally
3/24/2024
Few drug discovery and development concepts are as hyped, and as such, draw as much polarity from drug developers, as machine learning and artificial intelligence. One company on the bullish end of the spectrum is Flagship Pioneering's Generate: Biomedicines, which bills itself at the "intersection of machine learning, biological engineering, and medicine."